Tirzepatide Peptide – Premium Research Grade
Dual GIP & GLP-1 Receptor Agonist | ≥99% Purity | HPLC-Tested | Lyophilized Powder
Product Overview
Tirzepatide is a synthetic 39-amino acid peptide engineered as a dual agonist of GIP (Glucose-Dependent Insulinotropic Polypeptide) and GLP-1 (Glucagon-Like Peptide-1) receptors. Its dual-incretin mechanism represents a significant advancement over single GLP-1 agonists like Semaglutide, allowing researchers to simultaneously investigate two distinct but complementary metabolic receptor pathways within a single experimental model.
Structurally based on the native GIP sequence with key modifications that enhance GLP-1 receptor affinity and extend biological half-life to approximately 5 days, Tirzepatide occupies a unique position in metabolic research — more complex than single agonists, yet more targeted than triple agonists like Retatrutide. This makes it an essential compound for researchers mapping the individual and combined contributions of GIP and GLP-1 signalling to metabolic function.
Mechanism of Action
Tirzepatide’s dual receptor profile enables simultaneous activation of two incretin hormone pathways with distinct but synergistic metabolic roles:
GIP Receptor Activation — GIP is an incretin hormone secreted by intestinal K-cells in response to nutrient ingestion. GIP receptor activation influences insulin secretion in a glucose-dependent manner and plays a significant role in lipid metabolism and adipose tissue function. Tirzepatide’s GIP agonism allows researchers to study how this pathway contributes to metabolic regulation independently and in combination with GLP-1 signalling.
GLP-1 Receptor Activation — GLP-1 receptor agonism is one of the most studied mechanisms in metabolic research. Tirzepatide activates GLP-1 receptors across pancreatic, central nervous system, and gastrointestinal tissues, enabling investigation of glucose-dependent insulin secretion, appetite and satiety signalling, and gastric emptying modulation — the same pathways studied with Semaglutide but now in the context of simultaneous GIP activation.
Dual-Incretin Synergy — A key area of research interest is how simultaneous GIP and GLP-1 receptor activation produces effects that differ from either pathway alone. Tirzepatide is the primary research tool for investigating this dual-incretin synergy, particularly in the context of glucose homeostasis, adipose tissue metabolism, and energy balance.
Research Applications
Tirzepatide is widely used in laboratory investigations including:
- Dual GIP & GLP-1 receptor pharmacology and binding studies
- Glucose homeostasis and insulin secretion pathway research
- Adipose tissue metabolism and lipid regulation studies
- Appetite regulation and central satiety signalling analysis
- Comparative studies with single agonists like Semaglutide and triple agonists like Retatrutide
- Incretin hormone interaction and synergy research
- Combination metabolic studies alongside amylin analogs like Cagrilintide
Product Specifications
| Property | Detail |
|---|---|
| Peptide Type | Dual GIP & GLP-1 receptor agonist |
| Molecular Formula | C₂₂₅H₃₄₈N₄₈O₆₈ |
| Molecular Weight | ~4,813.45 g/mol |
| Amino Acid Length | 39 amino acids |
| Form | Lyophilized powder |
| Purity | ≥99% (HPLC verified) |
| Half-Life | ~5 days |
| Category | GLP-1 & metabolic research |
| Storage | -20°C long-term, 4°C short-term |
Storage & Reconstitution
Store lyophilized Tirzepatide at -20°C for long-term stability or at 4°C for use within 4–6 weeks. Protect from light and moisture at all times and keep vials tightly sealed until ready for use. Reconstitute with bacteriostatic water under sterile laboratory conditions. All reconstitution supplies are available in our accessories category.
Frequently Asked Questions — Tirzepatide
What is Tirzepatide used for in research? Tirzepatide is used in laboratory research to investigate dual GIP and GLP-1 receptor pharmacology, glucose homeostasis, insulin secretion, adipose tissue metabolism, appetite regulation, and incretin hormone synergy. It is a key compound in next-generation metabolic research.
How does Tirzepatide differ from Semaglutide? Semaglutide is a single GLP-1 receptor agonist. Tirzepatide adds GIP receptor activation, enabling researchers to study how dual-incretin engagement compares to GLP-1 agonism alone — making it valuable for isolating the specific contribution of GIP signalling to metabolic outcomes.
How does Tirzepatide compare to Retatrutide? Tirzepatide targets GLP-1 and GIP receptors. Retatrutide adds glucagon receptor activation to this profile, making it a triple agonist. Researchers use both compounds comparatively to study the additional metabolic effects of glucagon receptor engagement.
What purity level is your Tirzepatide? Every batch is HPLC-tested to ≥99% purity. Certificates of Analysis are available on request for all orders.
How should Tirzepatide be stored? Store at -20°C for long-term use or at 4°C for short-term use within 4–6 weeks. Keep away from light and moisture and store in a sealed vial until reconstitution.
Do you offer bulk pricing on Tirzepatide? Yes. Bulk discounts are available for research institutions and laboratories. Contact us directly for volume pricing details.
For research and laboratory use only. Not intended for human or veterinary consumption. Not for use in the diagnosis, treatment, cure, or prevention of any disease.
Reviews
There are no reviews yet.